BUPRENORPHINE 5 MCG/HR PATCH

buprenorphine
$20.9308per EA
DEA Schedule CIII

Strength

5 ug/h

Manufacturer

Alvogen Inc.

NDC

47781040604

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

2/18/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Generic (ANDA)

FDA Application

ANDA207490

On Market Since

5/17/2022

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

0.0%

3M

+0.2%

6M

-5.5%

1Y

-0.2%

3Y

-43.3%

5Y

N/A

All

-24.9%